Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2444718rdf:typepubmed:Citationlld:pubmed
pubmed-article:2444718lifeskim:mentionsumls-concept:C0206679lld:lifeskim
pubmed-article:2444718lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:2444718lifeskim:mentionsumls-concept:C2608085lld:lifeskim
pubmed-article:2444718lifeskim:mentionsumls-concept:C1824884lld:lifeskim
pubmed-article:2444718lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:2444718lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:2444718lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:2444718lifeskim:mentionsumls-concept:C0871161lld:lifeskim
pubmed-article:2444718lifeskim:mentionsumls-concept:C0597551lld:lifeskim
pubmed-article:2444718pubmed:issue11lld:pubmed
pubmed-article:2444718pubmed:dateCreated1987-11-30lld:pubmed
pubmed-article:2444718pubmed:abstractTextTo investigate the contribution of individual amino acids to the antigenicity of the N-terminal region of herpes simplex virus type 1 glycoprotein D, a series of 14 overlapping synthetic peptides within residues 1 to 30 were examined for their reactivity with monoclonal antibody LP14 (a group VII monoclonal antibody; in herpes simplex virus mutants resistant to LP14, arginine 16 is substituted by histidine) and two antipeptide antisera (antipeptide 9-21 and antipeptide 1-23). Maximal binding was achieved with peptides 9-21, 10-30, 9-30, and 8-30 and the chymotryptic fragment 9-17 of peptide 9-21, suggesting that a major antigenic site is located within residues 10 through 17. Lysine 10 was shown to be essential for high reactivity, either by binding directly to the antibody molecule or by stabilizing an ordered structure of the peptide. The importance of ordered structure was demonstrated by a decrease in reactivity after sodium dodecyl sulfate treatment of peptides 9-21 and 8-30.lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:languageenglld:pubmed
pubmed-article:2444718pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:citationSubsetIMlld:pubmed
pubmed-article:2444718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444718pubmed:statusMEDLINElld:pubmed
pubmed-article:2444718pubmed:monthNovlld:pubmed
pubmed-article:2444718pubmed:issn0022-538Xlld:pubmed
pubmed-article:2444718pubmed:authorpubmed-author:WellingG WGWlld:pubmed
pubmed-article:2444718pubmed:authorpubmed-author:Welling-Weste...lld:pubmed
pubmed-article:2444718pubmed:authorpubmed-author:FeijlbriefMMlld:pubmed
pubmed-article:2444718pubmed:authorpubmed-author:GeerligsH JHJlld:pubmed
pubmed-article:2444718pubmed:authorpubmed-author:WeijerW JWJlld:pubmed
pubmed-article:2444718pubmed:authorpubmed-author:BoschD LDLlld:pubmed
pubmed-article:2444718pubmed:issnTypePrintlld:pubmed
pubmed-article:2444718pubmed:volume61lld:pubmed
pubmed-article:2444718pubmed:ownerNLMlld:pubmed
pubmed-article:2444718pubmed:authorsCompleteYlld:pubmed
pubmed-article:2444718pubmed:pagination3607-11lld:pubmed
pubmed-article:2444718pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2444718pubmed:meshHeadingpubmed-meshheading:2444718-...lld:pubmed
pubmed-article:2444718pubmed:meshHeadingpubmed-meshheading:2444718-...lld:pubmed
pubmed-article:2444718pubmed:meshHeadingpubmed-meshheading:2444718-...lld:pubmed
pubmed-article:2444718pubmed:meshHeadingpubmed-meshheading:2444718-...lld:pubmed
pubmed-article:2444718pubmed:meshHeadingpubmed-meshheading:2444718-...lld:pubmed
pubmed-article:2444718pubmed:meshHeadingpubmed-meshheading:2444718-...lld:pubmed
pubmed-article:2444718pubmed:meshHeadingpubmed-meshheading:2444718-...lld:pubmed
pubmed-article:2444718pubmed:year1987lld:pubmed
pubmed-article:2444718pubmed:articleTitleStructural properties and reactivity of N-terminal synthetic peptides of herpes simplex virus type 1 glycoprotein D by using antipeptide antibodies and group VII monoclonal antibodies.lld:pubmed
pubmed-article:2444718pubmed:affiliationLaboratorium voor Medische Microbiologie, Rijksuniversiteit Groningen, The Netherlands.lld:pubmed
pubmed-article:2444718pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2444718pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2444718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2444718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2444718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2444718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2444718lld:pubmed